Carrie Liao - Feb 10, 2022 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
VP, Controller&Acct Principal
Signature
/s/ Robert Barrow, Attorney-in-Fact
Stock symbol
MNMD
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 06:12 PM
Previous filing
Jan 10, 2022
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNMD Subordinate Voting Shares Award $0 +403K $0.00 403K Feb 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNMD Stock Option (Right to Buy) Award $0 +524K $0.00 524K Feb 10, 2022 Subordinate Voting Shares 524K $1.34 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of 403,430 restricted stock units ("RSUs") on February 10, 2022. Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. 25% of the RSUs will vest on October 21, 2022; the remaining RSUs granted will vest with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2 The option grant has an exercise price of $1.71 Canadian Dollars. This represents the exercise price in United States Dollars.
F3 25% of the shares underlying the option shall vest and become exercisable on October 21, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.